Results 111 to 120 of about 70,255 (245)

Educational Artificial Intelligence Software to Support Assessment of Atopic Dermatitis Severity

The Journal of Dermatology, EarlyView.
ABSTRACT Accurate assessment of the severity of atopic dermatitis is crucial for guiding treatment. However, the Eczema Area and Severity Index (EASI), a widely used clinical assessment tool, relies on subjective visual scoring, which can lead to inter‐rater variability. This study aimed to evaluate the performance of convolutional neural network‐based
Kenichi Yamanaka, Yağmur Pak, Yoshihiro Inda, Toshiaki Nomi, Keisuke Ogaki, Masato Hoshi, Kouki Nakamura   +6 more
wiley   +1 more source

Real‐World Effectiveness, Treatment Course, and Safety of Tapinarof Cream 1% for Atopic Dermatitis and Plaque Psoriasis in Japan

The Journal of Dermatology, EarlyView.
ABSTRACT Background Tapinarof cream 1%, a non‐steroidal topical aryl hydrocarbon receptor‐modulating agent, is approved in Japan for atopic dermatitis (AD) and plaque psoriasis. Real‐world data on longitudinal outcomes, treatment continuation, interruption and restart, and adverse‐event timing are limited. Methods This single‐center retrospective study
Kanade Iino, Saori Takamura, Tomoo Fukuda   +2 more
wiley   +1 more source

Dupilumab induces a significant decrease of food specific immunoglobulin E levels in pediatric atopic dermatitis patients

Clinical and Translational Allergy
Lisa P. van derRijst, Michelle S. Hilbrands, Nicolaas P. A. Zuithoff, Marjolein S. deBruin‐Weller, André C. Knulst, Thuy‐My Le, Marlies deGraaf   +6 more
doaj   +1 more source

T-cell mechanisms in atopic dermatitis. [PDF]

Allergol Select
Baumann PC, Roesner LM.
europepmc   +1 more source

Correction to “Perceptions of a Group of Experts on the Integration of Artificial Intelligence in the Management of Atopic Dermatitis”

JEADV Clinical Practice, EarlyView.
wiley   +1 more source

Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Dupilumab is an anti‐interleukin (IL)‐4 receptor (IL‐4Rα) monoclonal antibody used to manage atopic dermatitis (AD). There is a paucity of real‐world Australian data for dupilumab in paediatric AD, especially regarding differences in clinical profiles between age groups.
Paul Sun Woo Kim, Jacqueline Tu, Kelvin Truong, Gloria Fong, William Luu, Peter Barclay, Melanie Wong, Li‐Chuen Wong   +7 more
wiley   +1 more source

Culturally Safe and Decentralised Care: Patient Experiences of a Dermatology Clinic Embedded in an Aboriginal and Torres Strait Islander Primary Health Care Service

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background Skin disease is a major cause of morbidity in Australia and a leading reason for primary care visits. Aboriginal and Torres Strait Islander peoples experience a disproportionate burden of skin conditions but face barriers to accessing culturally safe specialist services.
Nikhil Dwivedi, Nicholas Van Rooij, Geoffrey Spurling, Claudette (Sissy) Tyson, Sonya Egert, Erin McMeniman, Noel Hayman   +6 more
wiley   +1 more source

Contact Allergens Relevant to LGBTQI Populations: A Narrative Review and Practical Considerations

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Allergic contact dermatitis (ACD) is a common inflammatory skin disorder with significant morbidity across populations. Sexual and gender minority (SGM) individuals, including LGBTQI populations, are exposed to unique allergens due to gender‐affirming medical therapies, surgical interventions, cosmetics and grooming practices, sexual health ...
Nicholas van Rooij
wiley   +1 more source

Atopic dermatitis reconsidered: Clinical mimics and diagnostic pearls. [PDF]

J Am Acad Dermatol
Lawrence CN, Karagounis TK, Cohen DE.
europepmc   +1 more source

Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series

Australasian Journal of Dermatology, EarlyView.
ABSTRACT We present three patients who developed allergic contact dermatitis (ACD) from benzalkonium chloride (BAK) in ophthalmic drops. BAK is a preservative commonly found in ophthalmic formulations and there is a rising trend of ACD to this allergen. The irritant and sensitising properties of BAK on the ocular mucosa will be discussed.
Arav Kannen, Penelope Harrison, Elizabeth Christou   +2 more
wiley   +1 more source